{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:36:13Z","timestamp":1785306973095,"version":"3.55.0"},"reference-count":8,"publisher":"The Japanese Society for Medical Mycology","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Mycology Journal"],"published-print":{"date-parts":[[2016]]},"DOI":"10.3314\/mmj.57.j71","type":"journal-article","created":{"date-parts":[[2016,5,30]],"date-time":"2016-05-30T18:38:18Z","timestamp":1464633498000},"page":"J71-J75","source":"Crossref","is-referenced-by-count":8,"title":["Oral Antifungal Drugs in the Treatment of Dermatomycosis"],"prefix":"10.3314","volume":"57","author":[{"given":"Yuichiro","family":"Tsunemi","sequence":"first","affiliation":[{"name":"Department of Dermatology, Tokyo Women&rsquo;s Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1842","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"7) Hata K, Kimura J, Miki H, Toyosawa T, Nakamura T, Katsu K: <I>In vitro<\/I> and <I>in vivo<\/I> antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum. Antimicrob Agents Chemother 40: 2237-2242, 1996.","DOI":"10.1128\/AAC.40.10.2237"},{"key":"2","doi-asserted-by":"crossref","unstructured":"8) Fung-Tomc JC, Huczko E, Minassian B, Bonner DP: <I>In vitro<\/I> activity of a new oral triazole, BMS-207147 (ER-30346). Antimicrob Agents Chemother 42: 313-318, 1998.","DOI":"10.1128\/AAC.42.4.993"},{"key":"3","doi-asserted-by":"crossref","unstructured":"9) Pfaller MA, Messer SA, Hollis RJ, Jones RN, Diekema DJ: <I>In vitro<\/I> activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of <I>Candida<\/I> spp. Antimicrob Agents Chemother 46: 1723-1727, 2002.","DOI":"10.1128\/AAC.46.6.1723-1727.2002"},{"key":"4","doi-asserted-by":"crossref","unstructured":"10) Pfaller MA, Messer SA, Hollis RJ, Jones RN: SENTRY Participants Group: Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of <I>Aspergillus<\/I> spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000. Antimi-crob Agents Chemother 46: 1032-1037, 2002.","DOI":"10.1128\/AAC.46.4.1032-1037.2002"},{"key":"5","doi-asserted-by":"crossref","unstructured":"11) Gupta AK, Kohli Y, Batra R: <I>In vitro<\/I> activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species. Med Mycol 43: 179-185, 2005.","DOI":"10.1080\/13693780410001731583"},{"key":"6","doi-asserted-by":"crossref","unstructured":"12) Gupta AK, Leonardi C, Stoltz RR, Pierce PF, Conetta B, Ravuconazole onychomycosis group: A phase I\/II randomized, double-blind, placebo-controlled, dose-ranging study evaluating the efficacy, safety and pharmacokinetics of ravuconazole in the treatment of onychomycosis. J Eur Acad Dermatol Venereol 19: 437-443, 2005.","DOI":"10.1111\/j.1468-3083.2005.01212.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"13) Singh J, Zaman M, Gupta AK: Evaluation of micro-dilution and disk diffusion methods for antifungal susceptibility testing of dermatophytes. Med Mycol 45: 595-602, 2007.","DOI":"10.1080\/13693780701549364"},{"key":"8","doi-asserted-by":"crossref","unstructured":"15) Ueda Y, Matiskella JD, Golik J, Connolly TP, Hudyma TW, Venkatesh S, Dali M, Kang SH, Barbour N, Tejwani R, Varia S, Knipe J, Zheng M, Mathew M, Mosure K, Clark J, Lamb L, Medin I, Gao Q, Huang S, Chen CP, Bronson JJ: Phosphonooxymethyl prodrugs of the broad spectrum antifungal azole, ravuconazole: synthesis and biological properties. Bioorg Med Chem Lett 13: 3669-3672, 2003.","DOI":"10.1016\/j.bmcl.2003.08.029"}],"container-title":["Medical Mycology Journal"],"original-title":["\u76ae\u819a\u771f\u83cc\u75c7\u6cbb\u7642\u306b\u304a\u3051\u308b\u7d4c\u53e3\u6297\u771f\u83cc\u85ac\u306e\u6d3b\u7528"],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mmj\/57\/2\/57_J71\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,8]],"date-time":"2019-09-08T21:50:24Z","timestamp":1567979424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mmj\/57\/2\/57_J71\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.3314\/mmj.57.j71","relation":{},"ISSN":["2185-6486","2186-165X"],"issn-type":[{"value":"2185-6486","type":"print"},{"value":"2186-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}